Maribavir (GW257406X) is an orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of the viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV that are resistant to standard anti-CMV agents.
Molecular Weight:
376.24
Purity:
99.85%
CAS Number:
[176161-24-3]
Formula:
C15H19Cl2N3O4
Target:
Virus Protease|||Antifection|||HCV Protease
T2162
* VAT and and shipping costs not included. Errors and price changes excepted
